RestorEar is at the forefront of advancing clinical applications of therapeutic hypothermia to create surgical and clinical solutions for middle and inner ear disorders including noise-induced hearing loss (NIHL), tinnitus, traumatic brain injury (TBI), and relief from surgical trauma. Our products are the result of years of development effort and collaboration with our clinical partners. Partial support for our R&D and that of our collaborators comes from the National Institutes of Health, the Department of Defense, and the Department of Veterans Affairs.
Introducing
TECHNOLOGY FOR IMPROVED OUTCOMES IN COCHLEAR IMPLANT SURGERY
ReSurg™ harnesses our novel cooling technology to preserve residual (“natural”) hearing function during and after cochlear implant surgery. ReSurg was developed in collaboration with leading researchers, neurotologists, and audiologists to advance patient outcomes without interfering with surgical workflow, the implant device, or patient safety. ReSurg is set to undergo human trials in patients receiving cochlear implants in 2024
Stay up to date on our clinical trials by visiting clinicaltrials.gov.
OTHER CLINICAL TRIALS
RestorEar and our collaborators have collected preliminary human data for our cutting-edge products designed to address the problems of noise-induced hearing loss and chronic tinnitus. Clinical trials for these conditions are being expanded in 2024.
COLD THERAPY RESEARCH
Want to learn more about the research behind our products? The publications below highlight the science behind our products, and its benefit to hearing health.
Targeted therapeutic hypothermia protects against noise induced hearing loss
Transcriptional response to mild therapeutic hypothermia in noise-induced cochlear injury
Therapeutic hypothermia reduces cortical inflammation associated with Utah array implants
Mild therapeutic hypothermia protects against inflammatory and proapoptotic processes in the rat model of cochlear implant trauma
Additive Protective Effects of Delayed Mild Therapeutic Hypothermia and Antioxidants on PC12 Cells Exposed to Oxidative Stress
A cool approach to reducing electrode-induced trauma: localized therapeutic hypothermia conserves residual hearing in cochlear implantation
RestorEar Research is supported in part by
RestorEar and ReBound are FDA Registered | ReBound and ReSurg are proudly made in the USA.
RestorEar products and technologies are protected by numerous US and foreign patents, and pending patents.